Nano X Imaging Ltd - Asset Resilience Ratio
Nano X Imaging Ltd (NNOX) has an Asset Resilience Ratio of 6.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Nano X Imaging Ltd (NNOX) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2025)
This chart shows how Nano X Imaging Ltd's Asset Resilience Ratio has changed over time. See Nano X Imaging Ltd balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Nano X Imaging Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Nano X Imaging Ltd (NNOX) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $10.46 Million | 6.45% |
| Total Liquid Assets | $10.46 Million | 6.45% |
Asset Resilience Insights
- Limited Liquidity: Nano X Imaging Ltd maintains only 6.45% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Nano X Imaging Ltd Industry Peers by Asset Resilience Ratio
Compare Nano X Imaging Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Nano X Imaging Ltd (2020–2025)
The table below shows the annual Asset Resilience Ratio data for Nano X Imaging Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.45% | $10.46 Million | $162.16 Million | -9.69pp |
| 2024-12-31 | 16.14% | $33.90 Million | $210.00 Million | +4.25pp |
| 2023-12-31 | 11.89% | $26.01 Million | $218.65 Million | -3.53pp |
| 2022-12-31 | 15.42% | $39.16 Million | $253.93 Million | +9.35pp |
| 2021-12-31 | 6.08% | $22.07 Million | $363.17 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $236.15 Million | -- |
About Nano X Imaging Ltd
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source… Read more